Sword & Shield Pharma has informed that the Meeting of the Board of Directors of the Company will be held on February 04, 2017, to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 2016. Further, as per the Company’s Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the securities of the Company will be closed for all specified persons of the Company from January 27, 2017 to February 06, 2017.
The above information is a part of company’s filings submitted to BSE.